NCT07161154View on ClinicalTrials.gov

Sentio Systematic Evaluation

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Hearing Loss, Bilateral or UnilateralHearing Loss, ConductiveHearing Loss, Mixed Conductive-SensorineuralSingle Sided DeafnessHearing LossHearing-ImpairmentHearing Aid
Interventions
DEVICE

Transcutaneous bone conduction hearing system

The Sentio system is an active transcutaneous bone conduction hearing system (single armed study)

Sponsors

Lead Sponsor

Oticon Medical
All Listed Sponsors
lead

Oticon Medical

INDUSTRY

NCT07161154 - Sentio Systematic Evaluation | Biotech Hunter | Biotech Hunter